Introduction
Hypercoagulability is a significant complication of COVID-19 infection. It can lead to life-threatening situations when hypercoagulability manifests as clot burdens in vital organ systems. Keeping a low threshold for suspecting and treating hypercoagulability induced ischemia in vital organs is a crucial strategy to minimize the morbidity and mortality associated with it. (1)
Early recognition of various uncommon presentations and complications of COVID-19infection, subsequently leading to early management, is becoming increasingly important in recent times. We present a case of COVID-19 induced hypercoagulability leading to ST elevation myocardial infarction (STEMI) in a patient who developed cardiac failure ultimately requiring left ventricular assist device (LVAD) implantation.